Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Walgreen Expands AmerisourceBergen Strategic Partnership

Walgreen (NASDAQ: WBA  ) and strategic partner Switzerland-based Alliance Boots have entered into a 10-year agreement with pharmaceutical distribution wholesaler AmerisourceBergen (NYSE: ABC  ) , the companies announced Tuesday.

Walgreen took a 45% stake in Alliance Boots in June 2012, with the option to purchase the remaining shares within two years.

The new agreement expands on an existing relationship between Walgreen and AmerisourceBergen, and now includes primary distribution of generic and branded pharmaceutical products, scheduled to take effect Sept. 1. Terms of the contract are “market based,” and Walgreen said it expects only mild accretion in fiscal 2014, excluding one-time expenses.

AmerisourceBergen will work with the Walgreen/Alliance Boots Development global platform to enhance worldwide distribution processes. Walgreen and Alliance Boots also have the option to purchase as much as 7% of AmerisourceBergen’s stock in the open market.

Additionally, Walgreen and Alliance Boots received warrants for AmerisourceBergen stock, equal to a 16% equity position. The first warrants have a strike price of $51.50 per share, and are exercisable over a six-month period beginning March 2016. The remaining 8% stake will be available March 2017 and are also exercisable over six months, at a price of $52.50 a share.

AmerisourceBergen said the new agreements are expected to be "meaningfully accretive" to earnings. In FY 2014, the new relationship is expected to contribute an incremental $28 billion in revenues and approximately $0.20 in EPS, excluding the amortization of certain expenses related to the transaction, and certain non-recurring costs, and net of certain start up expenses.

Walgreen CEO Greg Wasson was quoted as saying: “We are excited to be expanding our existing relationship with AmerisourceBergen to a 10-year strategic long-term contract, representing another transformational step in the pharmaceutical supply chain.”


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2323490, ~/Articles/ArticleHandler.aspx, 9/28/2016 8:09:48 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 10 hours ago Sponsored by:
DOW 18,228.30 133.47 0.74%
S&P 500 2,159.93 13.83 0.64%
NASD 5,305.71 48.22 0.92%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/27/2016 4:00 PM
ABC $83.25 Up +0.53 +0.64%
AmerisourceBergen CAPS Rating: ****
WBA $80.97 Up +0.29 +0.36%
Walgreens Boots Al… CAPS Rating: ****